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bstract
bjectives  Development and internal validation of prognostic models for post-treatment and 1-year recovery in patients with neck pain in
rimary care.
esign  Prospective cohort study.
etting  Primary care manual therapy practices.
articipants  Patients with non-specific neck pain of any duration (n  = 1193).
ntervention  Usual care manual therapy.
utcome  measures  Recovery defined in terms of pain intensity, disability, and global perceived improvement directly post-treatment and
t 1-year follow-up.
esults  All post-treatment models exhibited acceptable discriminative performance after derivation (AUC ≥  0.7). The developed post-
reatment disability model exhibited the best overall performance (R2 = 0.24; IQR, 0.22–0.26), discrimination (AUC = 0.75; 95% CI,
.63–0.84), and calibration (slope 0.92; IQR, 0.91–0.93). After internal validation and penalization, this model retained acceptable discrimi-
ative performance (AUC = 0.74). The five other models, including those predicting 1-year recovery, did not reach acceptable discriminative
erformance after internal validation. Baseline pain duration, disability, and pain intensity were consistent predictors across models.
onclusion  A post-treatment prognostic model for disability was successfully developed and internally validated. This model has potential
o inform primary care clinicians about a patient’s individual prognosis after treatment, but external validation is required before clinical use
an be recommended.
 2021 The Authors. Published by Elsevier Ltd on behalf of Chartered Society of Physiotherapy. This is an open access article under the CC
Y license (http://creativecommons.org/licenses/by/4.0/).
ontribution  of  the  paper Existing prognostic models for patients with non-specific neck pain present substantial methodological shortcomings, which prevent their
clinical use. We developed and internally validated prognostic models to predict rec
 The prognostic model for post-treatment disability exhibited good perf
and clinical use.
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(NBQ-DV)  anxiety and depression subscale [28–30]). Addi-
tionally, the authors considered other potentially relevant2 R.W. Wingbermühle et al. /
ntroduction
Neck pain is a top five cause of Years Lived with Dis-
bility in high and middle income countries and, after low
ack pain, the second worldwide largest cause of muscu-
oskeletal disability [1]. Recovery from non-specific neck
ain mainly takes place in the first six weeks with very
ittle further long-term improvement of pain and disabil-
ty [2,3]. The prevalence of chronic neck pain, i.e. pain
asting longer than three months, has increased from 2005
o 2015 by 21% up to approximately 358 million people
orldwide and it is likely to increase further in West-
rn countries due to an ageing population [4]. Noninvasive
rimary care interventions (e.g. mobilisations and manipula-
ions, exercise, psychosocial interventions, or combinations)
re reported as effective treatments for non-specific neck
ain [5–7].
An accurate individual prognosis at intake can inform
linicians and patients in shared clinical decisions [8]. For
xample, in patients with a high risk of poor prognosis, sub-
equent effective treatment interventions may improve the
atients’ prognosis; at the same time, a wait-and-see approach
n patients with a very low risk of poor prognosis can limit
xposure to unnecessary treatments and reduce costs [8]. Sep-
rate prognostic factors which are consistently reported for
utcomes on neck-related pain, physical functioning, and per-
eived recovery are: age, sex, baseline pain intensity, baseline
isability, and past history of neck pain [9–11]. Prognos-
ic prediction models (in short: prognostic models) provide
robabilities for patients based on their individual combina-
ion of predictor values and can support clinicians in their
linical decisions [12]. Prognostic models have been shown
o improve prognostic accuracy in various healthcare fields
13,14]. However, a recent systematic review concluded that
he clinical utility of currently available prognostic mod-
ls in people with neck pain is limited [15]. Overall, the
ethodological quality of the studies included in this review
as low with the large majority of studies lacking suffi-
ient sample size and internal validation [15]. Furthermore,
rom the three promising models as defined in the systematic
eview, two appeared invalid in a subsequent external valida-
ion study and a third model specifically focusing on patients
ith whiplash associated disorders could not be tested [16].
herefore, there is a need to develop a prognostic model for
ecovery in patients with neck pain that exhibits satisfactory
rediction. This model should be developed in a cohort of
atients with adequate sample size, and it should be internally
alidated.
The aim of this study was to develop and internally vali-
ate prognostic models that predict at intake post-treatment
nd 1-year follow-up recovery of neck pain, disability, and
lobal perceived improvement in patients treated with manual
herapy in primary care. ptherapy 113 (2021) 61–72
ethods
esign
For this model derivation study, the authors used data from
 prospective cohort study, the ‘Amersfoorts Nekonderzoek
f the Master manuele therapie Opleiding’ (ANIMO), con-
ucted from 2007 to 2009. In total, 345 manual therapists in
he Netherlands recruited 1311 consecutive patients between
8 and 80 years presenting with non-specific neck pain of
ny duration. Participants providing baseline data and hav-
ng signed informed consent were deemed eligible (n = 1193).
eck pain with or without associated arm pain was classified
s non-specific if the pain could not be attributed to a specific
nderlying pathology (i.e., no red flags were present). Study
haracteristics (e.g., setting, inclusion criteria, measurement
rocedures) have been described in detail elsewhere [17].
articipating patients received usual care multimodal manual
herapy which may have included specific joint mobiliza-
ions, high velocity thrust techniques, myofascial techniques,
iving advice, or specific exercises. Mean treatment duration
as 37.9 days, mean number of treatment sessions was 4.3.
he Erasmus Medical Centre Ethics Committee Rotterdam,
he Netherlands (MEC-2007-359) approved this study.
This study was conducted following the PROGRESS
roup recommendations [18] and reported according to the
ransparent Reporting of a multivariable prediction model
or Individual Prognosis or Diagnosis (TRIPOD) statement
19].
andidate  model  predictors
The authors based selection of candidate predictors for
he models on the literature and clinical credibility of vari-
bles in combination with their reliability, applicability, and
osts [20–23], while avoiding univariable pre-selection [8].
he following predictors were considered: age, sex, pre-
ious neck pain episode, neck pain duration (acute 0–6
eeks, sub-acute 6–12 weeks and chronic >12 weeks),
ain intensity (measured with a Numerical Rating Scale
NRS)), and disability (Neck Disability Index – Dutch version
NDI-DV)) [11,24,25]. Furthermore, the authors included
ix additional candidate predictors regarded in the litera-
ure as clinically credible and relatively easy to collect at
ntake [9,11,25]: accompanying headache (yes/no),  accom-
anying low back pain (yes/no),  accompanying radiating arm
ain (yes/no),  smoking status (yes/no), fear-avoidance beliefs
Fear-Avoidance  Beliefs  Questionnaire  –  Dutch  version
FABQ-DV) physical activity subscale [26,27]), and psycho-
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ems (yes/no), partaking in sporting activities (yes/no), and
atients’ expectation to change due to treatment (5-point
ikert scale,  ranging  from  ‘much  better’  to  ‘much  worse’)
31].
utcomes
In this study, recovery was used as an umbrella term
or three different constructs and outcome measures, which
ere: (1) for pain as an NRS (10-point  Likert  scale)  score
ichotomized into >2 for non-recovery and ≤2 for recov-
ry as the latter is considered as a satisfactory state by
atients [32]; (2) for disability, by dichotomizing the NDI-
V (0–50  scale  range), after values were multiplied by two
o yield percentages, into <8% for recovery and ≥8% for non-
ecovery, which is a threshold used before [33,34]; and (3)
or global perceived improvement as Global Perceived Effect
GPE) measured on a 7-point Likert scale where recovery
as defined by response options “completely recovered” or
much improved”, while non-recovery by responses “slightly
mproved”, “no change”, “slightly worse”,” much worse”,
nd “worse than ever” represented non-recovery [35,36] Post-
reatment follow-up was measured in ANIMO immediately
fter a course of treatment and defined as no more than three
onths after intake, and long-term follow-up was measured
fter one year from inclusion. Outcome questionnaires were
eturned by post through provided prepaid envelopes.
issing  values
Missing values were evaluated by comparing patients with
nd without missing values on relevant predictors and by
erforming t-tests [37–40]. Missing At Random (MAR) was
ost plausible based on the data not being MCAR accord-
ng to compared patients and the performed t-tests. Multiple
mputation on predictors as well as outcomes using all pre-
ictor and outcome variables was performed [38–41]. The
ethod of Multivariate Imputation by Chained Equations
MICE) procedure with generation of 50 imputed data sets
as applied [41]. Regression coefficient estimates and stan-
ard errors were pooled according to Rubin’s Rules, and
odel performance measures estimated in each of the 50
ompleted datasets and then combined [39,42,43].
tatistical  analysis
Regression model assumptions such as linear relationship
etween predictor variables and the outcome were evaluated
sing restricted cubic splines and multicollinearity (Tol-
rance > 0.2, Variance Inflation Factor < 3). Variables were
oded before entering the regression models and categorical
ariables were transformed into dummy variables [44–46].
Multivariable logistic regressions were estimated for all
he models in the imputed ANIMO datasets as primary anal-
sis. A backward elimination approach with the P-value set
t <0.157 was used as this corresponds to the Akaike infor-
ation criterion [43,47]. Overall performance was expressed
B
w
therapy 113 (2021) 61–72 63
s Nagelkerke’s R2; calibration was estimated by the calibra-
ion slope, calibration curve, and the Hosmer–Lemeshow test;
nd the Area Under Curve (AUC) of the receiver-operating
haracteristic Curve (ROC) was calculated for quantifying
iscriminative performance [8,23]. Perfect discriminative
erformance has a value of 1 and the authors considered dis-
riminative performance acceptable if AUC was ≥0.7 [48].
he calibration plot is obtained across multiply imputed data
ets by the following approach that is commonly used to make
 calibration plot. In each imputed dataset the predicted prob-
bilities are determined and used to make 10 groups by using
0 deciles. Within these groups the observed outcomes were
ivided by the sample size of each group to obtain the pre-
icted probabilities. The agreement between these 10 groups
s plotted on the calibration curve and a natural cubic spline
urve is plotted between the black dots. The groups and cali-
ration curves of each imputed data set are plotted in the same
gure, distinguished by the multiple blue lines and multiple
lack dots for the groups. This makes it possible to evaluate
greement across multiply imputed data sets. Internal val-
dation of all models was performed with bootstrapping in
50 samples, and repeating all development steps. [49]. The
uthors corrected the models’ regression coefficients with
he optimism-adjusted calibration slope value and updated
he intercept using an “offset” procedure by calculating the
inear predictor with the new regression coefficients fixed
50]. All analyses were performed in IBM SPSS 24.0 and R
ersion 3.4.3.
ensitivity  analyses
In addition, the authors estimated all models and their per-
ormance measures on the complete case data as sensitivity
nalyses to allow comparison of models and performance
easures obtained on the imputed data.
ample  size  and  candidate  model  predictors
The authors performed a  priori  sample size calculations
or each model to decide on the amount of candidate pre-
ictor parameters, using the procedure described by Riley
t al. with a shrinkage of 0.8 and R2 of 0.1 [51]. The propor-
ion post-treatment non-recovery was 21%, 58%, and 21%
or pain intensity, disability, and global perceived improve-
ent, respectively, and after 1 year it was 45%, 62%, and
9%, respectively. This resulted in a maximum amount of
andidate predictor categories, depending on these outcome
roportions, ranging from 14 to 18. Calculations were made
ith the pmsamplesize package in R.
esultsaseline  characteristics  and  candidate  model  predictors
Patients’ baseline characteristics and candidate factors
ere comparable for complete cases (Supplement 2) and
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Table 1
Baseline characteristics and candidate model predictors of patients with non-specific neck pain (n = 1193).
Baseline characteristics Missing n (%)
Age (years), mean (SD) 44.7 (13.7) 23 (2)
Gender 7 (1)
Female sex, n (%) 823 (69)
Previous neck pain episode 64 (5)
Yes, n (%) 755 (67)
Neck pain duration 122 (10)
Acute 0 to 6 weeks, n (%) 420 (39)
Subacute 6 to 12 weeks, n (%) 138 (13)
Chronic >12 weeks, n (%) 513 (48)
Pain intensity (NRS, scale 1 to 10)c, mean (SD) 4.8 (2.1) 10 (1)
Disability (NDI, scale 0 to 50)d, median [IQR] 12.0 [8.0 to 17.0] 97 (8)
Accompanying headache 0 (0)
Yes, n (%) 707 (59)
Accompanying low back pain 0 (0)
Yes, n (%) 538 (45)
Accompanying radiating arm pain 0 (0)
Yes, n (%) 536 (45)
Accompanying general sleeping problems 0 (0)
Yes, n (%) 337 (28)
Smoking status 3 (0)
Yes, n (%) 300 (25)
Fear-avoidance believes (FABQ-PA, scale 0 to 24)a, median [IQR] 11.0 [6.0 to 15.0] 85 (7)
Emotional functioning (NBQ-AD, scale 0 to 20)b, median [IQR] 7.0 [3.0 to 10.0] 16 (1)
Partaking in sporting activities 4 (0)
Yes, n (%) 783 (66)
Patients’ expectation to change due to treatment 3 (0)
Much better, n (%) 517 (43)
Better, n (%) 662 (56)
No change, n (%) 10 (1)
Worse, n (%) 1 (0)
Much worse, n (%) 0 (0)
% rounded up to closest integer.



































NBQ-AD = Neck Bournemouth Questionnaire, anxiety and depression s
c NRS = numeric rating scale.
d NDI = neck disability index.
ases with no outcome data (Table 1). Mean age of patients
as 44.7 (SD 13.7) years, 69% (n  = 823) were female, and
7% (n  = 755) experienced a previous episode and 48%
n = 513) was classified as chronic. Mean baseline pain inten-
ity was 4.8 (SD 2.1) and median disability was 12.0 [IQR
.0–17.0]. The candidate factor for treatment expectations
as excluded since it showed an extreme standardised error
nd coefficient during model estimation.
utcome  values
Outcome values are presented in Table 2. Pain intensity
as 2.0 [IQR 1.0–2.0] and 2.8 [IQR 1.0–4.0] post-treatment
nd at 1-year, respectively. Disability was 5.0 [IQR 1.0–9.0]
nd 5.0 [IQR 2.0–8.0] post-treatment and at 1-year, respec-
ively.issing  values
Several baseline characteristics had more than 5% missing




 (scale 0–20), sum score of 11-point numeric subscale of items 4 and 5.
es reached about 45% missing values and the post-treatment
bout 55% (Table 2). Baseline characteristics were com-
arable between complete cases (Supplement 2) and those
ithout outcome data, and the means of several variables
iffered significantly depending on the missingness of indi-
ator variables, indicating that the MAR assumption is more
lausible. Therefore, the authors assumed data were MAR.
he authors chose 50 imputed datasets as the rule of thumb
s the number of imputations is as large as the percentage of
issing data [41]. In fact, the authors had missing data of
6, 43, 43, 53, 54 and 56% in the outcomes. This is on aver-
ge 42% for all outcomes. The authors applied one run of 50
mputed datasets and developed the different models in the
ame imputed data to eliminate the influence of missing data
mputation on the development of the models. Multicollinear-
ty in the MI model was not checked, but checked between
ariables before the models were developed. Further, the
uthors evaluated the convergence plots of the imputed vari-
bles and these showed healthy convergence, i.e., no irregular
atterns were visible, which is often an indication of that there
s no multicollinearity between variables.
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Table 2
Pain intensity, disability, and perceived recovery post-treatment (n = 1125)a and at 1 year (n = 1193).
Outcomes Post-treatmenta Missing, n % 1 year Missing, n %
Pain intensity (NRS, 1 to 10 scale)e, median [IQR] 2.0 [1.0 to 2.0] 591 (53) 2.0 [1.0 to 4.0] 552 (46)
Not recoveredb, n % 112 (21) 286 (45)
Disability (NDI, 0 to 50 scale)f, median [IQR] 5.0 [1.0 to 9.0] 628 (56) 5.0 [2.0 to 8.0] 515 (43)
Not recoveredc, n % 290 (58) 423 (62)
Global perceived improvement (GPE, 7-point Likert scale)g, n % 605 (54) 508 (43)
Completely recovered 127 (24) 149 (23)
Much improved 287 (55) 247 (39)
Slightly improved 83 (16) 143 (22)
No change 24 (5) 81 (13)
Slightly worse 0 (0) 11 (2)
Much worse 0 (0) 8 (1)
Worse than ever 0 (0) 2 (0)
Not recoveredd, n % 107 (21) 264 (39)
% rounded up to closest integer.
a Defined as no more than three months after intake, n = 68 not eligible.
b Not recovered >2, recovered ≤2.
c Score multiplied by 2 to yield %, not-recovered ≥8%, recovered <8%.
d Not recovered as “slightly improved”, “no change”, “slightly worse”, much worse”, “worse than ever”; recovered as “completely recovered” or “much
improved”.












































NDI = neck disability index.
g GPE = global perceived effect.
erived  models
The derived models for post-treatment prediction are
escribed in Table 3 and Supplement 1 and those for 1-year
rediction in Table 4. The authors compared spline models’
erformance to linear models’ performance for non-linear
ariable and outcome relations (i.e. Disability model at 1 year
nd Disability model post-treatment). Spline models’ perfor-
ance appeared not superior to linear models’ performance
nd the authors choose to present these as linear models as
hey are more straightforward for clinical use. Models’ inter-
ept, predictors, and assigned weights (beta’s) are displayed
ogether with their performance and optimism-adjusted per-
ormance measures as evaluated in imputed data [8]. For all
odels the Hosmer–Lemeshow test was not-significant.
All derived post-treatment models exhibited acceptable
iscriminative performance. The disability model obtained
he highest discriminative performance, and showed a cali-
ration slope of 0.92 (IQR, 0.91–0.93), and R2 of 0.24 (IQR,
.22–0.26). The derived post-treatment pain and perceived
mprovement models exhibited somewhat lower discrimina-
ive performance, with calibration slope values of 0.86 (IQR,
.91–0.93) and 0.86 (IQR, 0.84–0.87), respectively, and low
xplained variances. Calibration plots of post-treatment mod-
ls are presented in Fig. 1. After adjustment for optimism,
nly the post-treatment disability model retained acceptable
iscriminative performance of AUC 0.74 (IQR, 0.72–0.75),




None of the 1-year models reached the level of acceptable
iscriminative performance after derivation and after adjust-
ent for optimism, and showed lower calibration slope values
nd explained variances.
redictors  in  the  models
Neck pain duration was a predictor in all models (Supple-
ent 3). Baseline pain was a predictor in all pain models and
aseline disability in all disability models. Age was a predic-
or included in all post-treatment models and headache in all
-year models.
ensitivity  analyses
Sensitivity analyses on complete cases (post-treatment
ain, disability, perceived improvement models, n  = 532,
95, 518 respectively; 1-year pain, disability, perceived
mprovement models, n = 476, 508, 511 respectively) showed
omparable performance measure values. The post-treatment
ain model and the 1-year models derived in complete case
ata yielded the same or almost the same predictors (Supple-
ent 3). The post-treatment disability model in the complete
ases contained also sporting and previous episode as predic-
ors and the perceived improvement model did not contain



















Performance of prognostic models for predicting post-treatment recovery of neck pain (n = 1193)#.
Predictors Coefficient ## OR ## R2 Optimism-adjusted R2 AUC Optimism-adjusted AUC
Pain modela *
Constant −3.62 (−4.66, −2.57) 0.03 (0.01 to 0.08)
0.13 [0.12 to 0.14] $ 0.09 [0.08 to 0.11] $ 0.70 (0.56 to 0.81) $$ 0.67 [0.66 to 0.69] $
Subacute pain 0.44 (−0.24, 1.13) 1.56 (0.78 to 3.10)
Chronic pain 0.96 (0.47, 1.46) 2.62 (1.60 to 4.31)
Baseline pain (NRS 0 to 10)d 0.19 (0.07, 0.31) 1.21 (1.07 to 1.36)
BNQ anxiety & depression (0 to 20)e 0.04 (−0.00, −0.10) 1.05 (1.00 to 1.10)
Age 0.01 (−0.00, 0.02) 1.01 (1.00 to 1.02)
Disability modelb **
Constant −2.75 (−3.58, −1.93) 0.06 (0.03 to 0.15)
0.24 [0.22 to 0.26] $ 0.21 [0.19 to 0.23] $ 0.75 (0.63 to 0.84) $$ 0.74 [0.72 to 0.75] $
Subacute pain 0.30 (−0.27, 0.86) 1.34 (0.77 to 2.36)
Chronic pain 0.96 (0.53, 1.40) 2.62 (1.70 to 4.03)
Baseline disability (NDI 0 to 50f 0.12 (0.08, 0.16) 1.13 (1.08 to 1.17)
Age 0.02 (0.01, 0.03) 1.02 (1.01 to 1.03)
General sleeping problems 0.31 (−0.10, 0.72) 1.36 (0.91 to 2.05
FABQ physical activity (0 to 24)g 0.02 (−0.01, 0.05) 1.02 (0.99 to 1.05)
Perceived improvement modelc ***
Constant −2.72 (−3.80, −1.64) 0.07 (0.02 to 0.19)
0.13 [0.11 to 0.15] $ 0.09 [0.07 to 0.11] $ 0.70 (0.56 to 0.80) $$ 0.67 [0.65 to 0.69] $
Subacute pain 0.16 (−0.70, 1.03) 1.18 (0.49 to 2.81)
Chronic pain 0.95 (0.46, 1.43) 2.57 (1.60 to 4.17)
Low back pain 0.41 (−0.02, 0.84) 1.51 (0.98 to 2.30)
FABQ physical activity (0 to 24) 0.04 (0.00, 0.08) 1.04 (1.00 to 1.08)
Age 0.01 (−0.00, 0.03) 1.02 (0.10 to 1.03)
Baseline disability (NDI 0 to 50) −0.03 (−0.07, 0.01) 0.97 (0.93 to 1.01)
Previous episode −0.46 (0.00, 0.08) 1.04 (1.00 to 1.08)
Partaking in sporting activities 0.38 (−0.05, 0.81) 1.46 (0.95 to 2.25)
#Imputed data; ## In logit scale as mean with 95% confidence interval (CI); $ In logit scale as median with interquartile range [IQR]; $$ In logit scale as mean with 95% CI.
a Pain intensity measured with NRS 1–10-point Likert scale); not-recovered >2.
b Disability measured with NDI 2 (0–50 scale, sum score multiplied by 2 to yield %); not-recovered ≥8%.
c General Perceived Effect measured with GPE 3 (7-point Likert scale); non-recovered as “slightly improved”, “no change”, “slightly worse”, much worse”, “worse than ever”.
d NRS = numeric rating scale (1–10-point Likert scale).
e NBQ-AD = Neck Bournemouth Questionnaire, anxiety and depression subscale (scale 0–20), sum score of 11-point numeric subscale of items 4 and 5.
f NDI = neck disability index (0–50 scale).


















Performance of prognostic models for predicting 1-year recovery of neck pain (n = 1193).#.
Predictors Coefficient ## OR ## R2 Optimism-adjusted R2 AUC Optimism-adjusted AUC
Pain modela
Constant −1.27 (−1.75, −0.80) 0.28 (0.17 to 0.45)
0.09 [0.08 to 0.10] $ 0.06 [0.05 to 0.07] $ 0.65 (0.52 to 0.76) $$ 0.62 [0.62 to 0.63] $
Baseline pain (NRS 0 to 10)d 0.13 (0.06, 0.21) 1.14 (1.06 to 1.24)
General sleeping problems −0.48 (−0.85, −0.12) 0.62 (0.43 to 0.88)
Previous episode 0.29 (−0.04, 0.62) 1.34 (0.96 to 1.86)
Low back pain 0.33 (0.03, 0.64) 1.40 (1.03 to 1.89)
Headache 0.30 (0.00, −0.60) 1.35 (1.00 to 1.83)
Disability modelb
Constant −1.01 (−1.69, 0.33) 0.36 (0.18 to 0.71)
0.09 [0.08 to 0.10] $ 0.06 [0.05 to 0.07] $ 0.65 (0.53 to 0.76) $$ 0.63 [0.62 to 0.64] $
Subacute pain 0.05 (−0.4, 0.51) 1.05 (0.66 to 1.67)
Chronic pain 0.48 (0.13, 0.84) 1.62 (1.13 to 2.32)
Baseline disability (NDI 0 to 50)e 0.05 (0.02, 0.08) 1.05 (1.02 to 1.08)
Age 0.01 (0.00, 0.02) 1.01 (1.00 to 1.02)
Headache 0.36 (0.01, 0.72) 1.44 (1.01 to 2.05)
Perceived improvement modelc
Constant −1.38 (−1.85, −0.92) 0.25 (0.16 to 0.40)
0.10 [0.09 to 0.11] $ 0.07 [0.06 to 0.08] $ 0.66 (0.53 to 0.77) $$ 0.64 [0.63 to 0.65] $
Subacute pain 0.37 (−0.16, 0.91) 1.45 (0.85 to 2.49)
Chronic pain 0.40 (0.03, 0.77) 1.49 (1.03 to 2.15)
Baseline disability (NDI 0 to 50) 0.04 (0.01, 0.06) 1.04 (1.01 to 1.06)
Low back pain 0.46 (0.13, 0.79) 1.58 (1.13 to 2.20)
General sleeping problems −0.40 (−0.76, −0.03) 0.67 (0.47 to 0.97)
Female gender −0.37 (−0.73, −0.01) 0.70 (0.48 to 0.99)
Headache 0.54 (0.22, 0.86) 1.72 (1.25 to 2.38)
#Imputed data; ## In logit scale as mean with 95% confidence interval (CI); $ In logit scale as median with interquartile range [IQR]; $$ In logit scale as mean with 95% CI.
a Pain intensity measured with NRS 1–10-point Likert scale); not-recovered >2.
b Disability measured with NDI 2 (0–50 scale, sum score multiplied by 2 to yield %); not-recovered ≥8%.
c General Perceived Effect measured with GPE 3 (7-point Likert scale); non-recovered as “slightly improved”, “no change”, “slightly worse”, much worse”, “worse than ever”.
d NRS = numeric rating scale (1–10-point Likert scale).
e NDI = neck disability index (0–50 scale).































































ig. 1. Calibration plots. a. Disability model. b. Pain model. c. Perceived im
iscussion
ain  result
The derived model for post-treatment disability contain-
ng baseline pain duration, baseline disability, age, sleeping
roblem and FABQ-physical activity as predictors exhibited
he best overall performance, calibration, and discrimination
nd it also exceeded the threshold for acceptable discrim-
native ability after adjustment for optimism. The other
ost-treatment models almost reached acceptable discrimi-
ative ability after adjustment. None of the derived 1-year
odels reached acceptable discriminative performance and
howed lower calibration slope values and explained vari-
nces.
mportant  results  models
The post-treatment models performed better than the 1-
ear models and exhibited discrimination of 0.70 or upward
nd calibration slopes more or less around a value of 0.90. Is
eems plausible that short-term prediction is more accurate
ompared to long-term prediction. The post-treatment dis-
bility model performed best, possibly because the outcome
as measured with the NDI, which is an instrument that cov-
rs various health constructs [52]. The NRS is a single-item
uestionnaire which measures a narrower domain and may
lso have larger measurement error that can influence the
erformance of the models [53]. The same may apply to the
PE which, additionally, is an instrument reflecting the cur-
ent health status more than change in health status over time
36].
On the whole, our derived models, especially the post-
reatment disability model, performed better as compared to
xisting models that predict recovery in neck pain patients,
lthough few derivation studies allow proper comparison of
odel performance as both discrimination and calibration






mportant  results  predictors
Neck pain duration was a predictor in all models and
ndependent of type of outcome or follow-up time. Baseline
isability was a predictor in almost all models except for pain
utcome. Baseline pain was a predictor in almost all mod-
ls except for disability outcome. Age was a predictor that
orresponded consistently with post-treatment follow-up and
eadache with 1-year follow-up.
odel  comparison  with  literature
One study with six months follow up and a GPE out-
ome derived a model in a primary care population (n  = 468)
reated for non-serious neck pain and validated this model
n a primary care setting treated with manual therapy and
lectrotherapy (n  = 346) [35]. This model performed less
ell if compared to the post-treatment model on GPE out-
ome in our study but similarly to the 1-year model. Its
xternal validation study revealed a possibly helpful dis-
riminative ability of AUC 0.65 (95% CI, 0.59 to 0.71), a
alue slightly better compared to our internal validation [35].
nother study developed models also using the NDI as an
utcome in people with acute whiplash associated disorder
WAD) at one-year [55]. Models’ overall performance (R2)
as presented but no model calibration and discrimination
ere calculated, which hampers comparison of model perfor-
ance. However, these models performed not well at external
alidation [16]. Another study developed a prognostic model
or WAD, with six months follow-up, in an insurance com-
any subcohort treated with physical therapy physiotherapy
nd collected self-reported recovery outcome through tele-
hone interview [56]. An AUC of 0.67 (95% CI, 0.63 to 0.70)
as reported after internal validation. This is comparable to
he post-treatment model on GPE outcome after internal val-
dation in our study and somewhat better compared to our
-year model after internal validation. In the current study,
he authors recruited patients with non-specific neck pain of
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rast with the two aforementioned studies, the authors did not
evelop a model specific for WAD.
redictors  in  the  models  compared  with  literature
A recent overview of systematic reviews on prognostic
actors in neck pain reported that higher baseline NDI and
ain at inception were predictors of outcomes after WAD
11]. In our study, in which patients with non-specific neck
ain and WAD were included, all models that predicted dis-
bility yielded baseline disability as predictor, and models
hat predicted pain contained baseline pain as predictor. This
s in line with the vast majority of models that predicted dis-
bility outcomes and pain outcomes as described in a recent
ystemic review [15]. Baseline NDI and baseline pain are
onsistent reported prognostic factors [11,24,25] for predic-
ion of disability and neck pain, respectively. This is also the
ase for neck pain duration as a consistently reported prog-
ostic factor [11,24,25] that retains its predictive ability in
elation to other prognostic factors for all outcomes as well
s age and headache who are consistently reported prognostic
actors [11,24,25] that retain their predictive ability in rela-
ion to other prognostic factors, for short-term and long-term
rognosis, respectively. Sex and previous neck pain episode
11,24,25] appeared less consistent in relation to other prog-
ostic factors.
trengths  and  limitations
In contrast with previously published prognostic models
or neck pain [15] the models in our study were developed in
 large cohort with sufficient power, and the cohort closely
esembles clinical practice in primary care manual therapy in
he Netherlands. The authors used the most recent methods
n terms of a  priori  model sample size calculation, develop-
ent, and internal validation. After internal validation, the
uthors presented penalized full models for the models that
emonstrated acceptable performance.
The main limitation of this study is the cohort’s missing
ata, especially for the outcome variables. The high dropout
an be explained by the fact that participants returned out-
ome questionnaire booklets by post that had to be number
arked by themselves and when this was missing the book-
ets could be labelled at their arrival by the researchers.
owever, the labels with the patient number on them were
requently lost or separated from the booklets and then the
otal questionnaire information could not be used anymore.
he authors think due to these reasons that the underly-
ng missing data mechanism tends towards an MCAR and
AR mechanism but certainly not MNAR. Also, because the
ajority of predictors are shared by MI and complete case
ata, especially for one-year follow-up and baseline charac-
eristics were comparable between complete cases and those
ithout outcome data. As recommended in the literature [41],
issing value analysis was conducted and multivariable mul-
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mount of 50 imputed sets. There is some evidence from sim-
lation studies that this high missing data rate can be handled
ith multiple imputation [57]. To address the potential limi-
ation of gain from imputation, complete case analyses were
lso performed as sensitivity analyses and these showed very
imilar parameter estimates and this consistency supports our
onclusions. Another limitation to be addressed is that the
uthors used binary outcomes for reason of comparison with
revious developed models. The use of other cut-offs may
ave resulted in other model predictors or model performance
nd the derived models have to be interpreted in relation to
he cut-offs points used at issue.
The authors reached sample size for the post-treatment
isability model and all 1-year models. However, the post-
reatment pain and perceived improvement models fell one
redictor parameter short to reach effective sample size (the
xcluded candidate factor for treatment expectations was
onsidered). The authors believe to have corrected for this
verfitting by penalizing the post-treatment models after
nternal validation.
onclusions
A post-treatment prognostic model for disability was suc-
essfully developed and internally validated. This model has
otential to inform primary care clinicians about a patient’s
ndividual prognosis after treatment, but external validation
s required before broad clinical use can be recommended.
mplications  for  practice  and  further  research
Recovery is a multidimensional construct and clinical
uidelines usually promote the use of several outcome
easures simultaneously [58]. For this reason, the authors
ropose that, if all adequately performing during external
alidation, the future potential clinical use will be of all
he three separate models developed in this study. The post-
reatment models for prediction of recovery in patients with
on-specific neck pain, especially the disability model, have
ood potential for clinical use. The post-treatment disability
odel can inform clinicians at intake about patient’s indi-
idual prognosis after therapy. To illustrate this for an intake
ituation where a physiotherapist wants to inform a neck pain
atient about his or her specific prognosis: “based on this
odel and you being 30 years of age, having 10 weeks neck
ain duration, a 7/50 NDI score, sleeping problems and a 4/24
ABQ-PA score, the authors expect there is a 35% chance you
ill not be recovered post-treatment (or vice-versa  a 65%
hance that you will be recovered after treatment). However,
efore clinical use can be promoted, the authors suggest post-
reatment models’ further external validation, especially the
isability model. The post-treatment disability model derived
n our study showed precise optimism-adjusted AUC of 0.74
ith small 95% CI width of 0.03. The authors argue this
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uit to avoid key methodological shortcomings and therefore
ikely obtaining models that are less overfitted than the large
ajority of those developed for neck pain so far [15]. Addi-
ionally, the post-treatment pain and perceived improvement
odels exhibited also precise optimism-adjusted AUCs of
.67 with small 95% CI widths of 0.03 and 0.04, respectively.
he authors strongly believe there is room to expand models’
erformance by updating these models with other predictors
hat were not evaluated in the ANIMO cohort (e.g., clinical
xamination findings).
The models’ relatively low explained variances indicate
otential for improvement with relevant predictors that are
till missing and literature knowledge seems to provide us
nly limited information. Further research on new predictors
hat can strengthen the models is needed. Furthermore, the
uthors suggest research on predictors of treatment effect
e.g. by randomized controlled trials), since they could not be
ccounted for in this single cohort study design. Specifically,
ausally related modifiable factors have potential to change
atient outcome [8].
thics  approval: Obtained from Erasmus Medical Centre,
otterdam, the Netherlands (Ref. No. MEC-2007-359).
Data was deidentified and the study complies with the
eclaration of Helsinki.
unding: This study was partly funded by a program grant
f the Dutch Arthritis Foundation. The funder played no role
n the design, conduct, or reporting of this study.
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